Follow
Emilio Berti
Emilio Berti
Prof. Ordinario di Dermatologia Università degli Studi di Milano
Verified email at unimi.it
Title
Cited by
Cited by
Year
WHO-EORTC classification for cutaneous lymphomas
R Willemze, ES Jaffe, G Burg, L Cerroni, E Berti, SH Swerdlow, ...
Blood 105 (10), 3768-3785, 2005
48352005
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
R Willemze, H Kerl, W Sterry, E Berti, L Cerroni, S Chimenti, ...
Blood, The Journal of the American Society of Hematology 90 (1), 354-371, 1997
16911997
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ...
leukemia 36 (7), 1703-1719, 2022
15602022
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ...
Leukemia 36 (7), 1720-1748, 2022
13722022
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
R Willemze, L Cerroni, W Kempf, E Berti, F Facchetti, SH Swerdlow, ...
Blood, The Journal of the American Society of Hematology 133 (16), 1703-1714, 2019
11112019
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases
R Willemze, PM Jansen, L Cerroni, E Berti, M Santucci, C Assaf, ...
Blood, The Journal of the American Society of Hematology 111 (2), 838-845, 2008
7292008
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+ Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3
G Penna, A Roncari, S Amuchastegui, KC Daniel, E Berti, M Colonna, ...
Blood 106 (10), 3490-3497, 2005
5282005
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior
E Berti, D Tomasini, MH Vermeer, CJLM Meijer, E Alessi, R Willemze
The American journal of pathology 155 (2), 483-492, 1999
5111999
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell …
NJ Senff, EM Noordijk, YH Kim, M Bagot, E Berti, L Cerroni, R Dummer, ...
Blood, The Journal of the American Society of Hematology 112 (5), 1600-1609, 2008
4942008
Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients
AV Marzano, G Genovese, G Fabbrocini, P Pigatto, G Monfrecola, ...
Journal of the American Academy of Dermatology 83 (1), 280-285, 2020
4902020
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary …
W Kempf, K Pfaltz, MH Vermeer, A Cozzio, PL Ortiz-Romero, M Bagot, ...
Blood, The Journal of the American Society of Hematology 118 (15), 4024-4035, 2011
4612011
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's …
C Parravicini, B Chandran, M Corbellino, E Berti, M Paulli, PS Moore, ...
The American journal of pathology 156 (3), 743-749, 2000
4442000
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
G Burg, W Kempf, A Cozzio, J Feit, R Willemze, E S. Jaffe, R Dummer, ...
Journal of cutaneous pathology 32 (10), 647-674, 2005
4362005
Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and …
JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ...
Journal of Clinical Oncology 33 (32), 3766, 2015
4152015
Primary cutaneous CD30‐positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients
RC Beljaards, P Kaudewitz, E Berti, R Gianotti, C Neumann, R Rosso, ...
Cancer 71 (6), 2097-2104, 1993
3621993
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European …
M Paulli, E Berti, R Rosso, E Boveri, S Kindl, C Klersy, M Lazzarino, ...
Journal of Clinical Oncology 13 (6), 1343-1354, 1995
3131995
Skin manifestations associated with COVID-19: current knowledge and future perspectives
G Genovese, C Moltrasio, E Berti, AV Marzano
Dermatology 237 (1), 1-12, 2021
2932021
Cytotoxic/natural killer cell cutaneous lymphomas: report of the EORTC cutaneous lymphoma task force workshop
M Santucci, N Pimpinelli, D Massi, ME Kadin, CJLM Meijer, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
2882003
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas
PL Zinzani, P Quaglino, N Pimpinelli, E Berti, G Baliva, S Rupoli, ...
J Clin Oncol 24 (9), 1376-82, 2006
2522006
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients
C Parravicini, SJ Olsen, M Capra, F Poli, G Sirchia, SJ Gao, E Berti, ...
Blood, The Journal of the American Society of Hematology 90 (7), 2826-2829, 1997
2461997
The system can't perform the operation now. Try again later.
Articles 1–20